Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

45 filings reported holding ALGS - Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share as of Q2 2025.
Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.71M shares of 5.29M outstanding shares and own 51.17% of the company stock.
Largest 10 shareholders include Woodline Partners LP (518K shares), Deep Track Capital, LP (444K shares), Alyeska Investment Group, L.P. (412K shares), Sio Capital Management, LLC (336K shares), TANG CAPITAL MANAGEMENT LLC (141K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (140K shares), VANGUARD GROUP INC (140K shares), READYSTATE ASSET MANAGEMENT LP (137K shares), BAKER BROS. ADVISORS LP (83.1K shares), and HHLR ADVISORS, LTD. (76.2K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.